8-K - Mangoceuticals, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Mangoceuticals, Inc. filed an 8-K on February 19, 2026, referencing Item 7.01 with an attached Exhibit 99.1 Press Release that is not deemed 'filed' under Section 18 of the Securities Exchange Act. Item 9.01 discloses the financial statements and exhibits including the press release and cover page interactive data.

Key Takeaways

1Filing date: 2026-02-19

2Form Type: 8-K

3Item 7.01 referenced with Exhibit 99.1 Press Release dated February 19, 2026

4Exhibit 99.1 not deemed 'filed' for Section 18 purposes

5Item 9.01 lists Exhibit 99.1 and Exhibit 104

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

by reference. The information in this Item 7.01 , including Exhibit 99.1 attached hereto, shall not be deemed “ filed ” for purposes of Section 18 of the Securi

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Press Release dated February 19, 2026 104 Cover Page Interactive Dat

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1